Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?
Schillaci
Orazio
O
University Tor Vergata, Rome, Italy. orazio.schillaci@uniroma2.it
D005770:Gastrointestinal Neoplasms / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology*; D009683:Nuclear Medicine / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods; D011859:Radiography; D011874:Radiometry / Q000379:methods; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin / Q000378:metabolism / Q000502:physiology*; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin